PetVivo Holdings, Inc.

Equities

PETV

US7168174081

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets Other stock markets 03:59:23 2024-04-26 pm EDT			5-day change	1st Jan Change
0.8197 ^USD	+2.46%		+11.52%	-22.67%

Apr. 11	PetVivo Holdings, Inc.(OTCPK:PETV) dropped from S&P TMI Index	CI
Apr. 10	PetVivo Holdings, Inc. announced that it has received $0.3 million in funding from A.L. Sarroff Management, LLC	CI

Leslie Coolidge and Scott Johnson Not to Stand for Re-Election as Board Directors of PetVivo Holdings, Inc

October 03, 2023 at 03:58 pm EDT

PetVivo Holdings, Inc. announced that Ms. Leslie Coolidge and Mr. Scott Johnson will not stand for reelection as Board of Directors at 2023 Annual Meeting of Stockholders to be held on November 17, 2023.

Latest news about PetVivo Holdings, Inc.

PetVivo Holdings, Inc.(OTCPK:PETV) dropped from S&P TMI Index	Apr. 10	CI
PetVivo Holdings, Inc. announced that it has received $0.3 million in funding from A.L. Sarroff Management, LLC	Apr. 09	CI
PetVivo Holdings, Inc.(OTCPK:PETV) dropped from NASDAQ Composite Index	Apr. 07	CI
PetVivo, ThinkEquity Terminate At-The-Market Offering Deal	Mar. 11	MT
PetVivo Names Garry Lowenthal its New Chief Financial Officer	Mar. 11	MT
Petvivo Holdings, Inc. Appoints Garry Lowenthal as Its New Chief Financial Officer	Mar. 11	CI
Transcript : PetVivo Holdings, Inc., Q3 2024 Earnings Call, Feb 12, 2024	Feb. 12
PetVivo Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 12	CI
Earnings Flash (PETV) PETVIVO HOLDINGS Posts Q3 Revenue $595,891	Feb. 12	MT
PetVivo Holdings, Inc. Announces Release of Clinical Study Results Involving Feline Tolerance to Intra-Articular Injections of Spryng? with Osteocushion? Technology	Feb. 07	CI
PetVivo Holdings, Inc. Announces Release of Clinical Study Results Involving Canine Tolerance to Intra-Articular Injections of Spryng with OsteoCushion Technology	Jan. 31	CI
Robert J. Folkes Resigns as Chief Financial Officer of PetVivo Holdings, Inc., Effective from February 2, 2024	Jan. 25	CI
Petvivo Receives Notice of Allowance from United States Patent and Trademark Office for Key Patent Application	Jan. 23	CI
PetVivo Holdings, Inc. Approves Election of Diane Levitan as Member of the Board	Nov. 22	CI
Transcript : PetVivo Holdings, Inc., Q2 2024 Earnings Call, Nov 14, 2023	Nov. 14
Earnings Flash (PETV) PETVIVO HOLDINGS Reports Q2 Revenue $207.4M	Nov. 14	MT
PetVivo Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 14	CI
Leslie Coolidge and Scott Johnson Not to Stand for Re-Election as Board Directors of PetVivo Holdings, Inc	23-10-03	CI
Sector Update: Health Care Stocks Slipping Late Afternoon	23-08-24	MT
Sector Update: Health Care Stocks Lower Thursday Afternoon	23-08-24	MT
PetVivo Signs At-The-Market Offering Deal for Common Stock	23-08-24	MT
PetVivo Gets Notice of Allowance From US Patent Office	23-08-17	MT
PetVivo Receives Notice of Allowance from United States Patent and Trademark Office for Key Patent Application	23-08-17	CI
Transcript : PetVivo Holdings, Inc., Q1 2024 Earnings Call, Aug 10, 2023	23-08-10
Earnings Flash (PETV) PETVIVO HOLDINGS Posts Q1 Revenue $117,183	23-08-10	MT

Chart PetVivo Holdings, Inc.

Duration

Period

More charts

Company Profile

PetVivo Holdings, Inc. is a biomedical device company. The Company is focused on the manufacturing, commercialization, and licensing of medical devices and therapeutics for animals. The Companyâs lead product Spryng with OsteoCushion Technology, is a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The Company is primarily engaged in the business of commercializing and licensing products in the veterinary market to treat and/or manage afflictions of companion animals, such as dogs and horses. Its products are derived from biomaterials that simulate a bodyâs cellular tissue by virtue of their reliance upon natural protein and carbohydrate compositions, which incorporate such tissue building blocks as collagen, elastin, and proteoglycans such as heparin. The Company has a pipeline of therapeutic devices for both veterinary and human clinical applications.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-06-26 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for PetVivo Holdings, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.8197 USD

Average target price

5 USD

Spread / Average Target

+509.98%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
PETVIVO HOLDINGS, INC.	-22.67%	13.75M
ABBOTT LABORATORIES	-2.31%	187B
MEDTRONIC PLC	-3.20%	106B
BECTON, DICKINSON AND COMPANY	-5.04%	66.9B
DEXCOM, INC.	+0.20%	49.45B
CENCORA, INC.	+17.29%	48B
HOYA CORPORATION	+4.06%	40.84B
WEST PHARMACEUTICAL SERVICES, INC.	+2.36%	26.25B
METTLER-TOLEDO INTERNATIONAL, INC.	+2.07%	26.48B
TERUMO CORPORATION	+12.96%	24.62B

Other Medical Equipment, Supplies & Distribution